FOI Foccini International

Foccini International Inc. ("Foccini" or the "Company") (TSX VENTURE:FOI)
announces it has acquired an option to purchase 100% ownership of Arch Biotech
Inc. ("Arch"), a company specializing in biomedical technology and drug
development. The option expires on December 1, 2009.


In the event Foccini exercises its option to acquire Arch, Foccini will
immediately notify the TSXV it is pursuing a Change of Business Application (the
"Transaction") pursuant to TSXV Policy 5.2 "Changes of Business and Reverse
Takeovers". The final closing of the acquisition of Arch will depend on the TSXV
approval of the Transaction.


About Arch Biotech

Arch has been established to acquire biomedical technology with commercial
potential and oversee its development until it can be sold or licensed to
suitable marketing partners.


Arch is a private Ontario corporation owned by: Mr. Jerome McElroy, co founder
of several biotech companies including MDS Health Services and Helix Bio Pharma;
Dr. Richard Rossman and Mr. Conor Gunne, who also served on the Helix board from
1995 to 2007; University of Calgary based scientists Dr. Daniel Muruve, Dr. Paul
Beck and Dr. Justin MacDonald and Richard Muruve, a current director of Foccini.


Terms of the Option to Acquire Arch

Foccini has agreed to pay $10,000 to Arch Biotech as consideration for the
option. Under the terms of the option, Foccini has agreed to dispose of its
merchandising operations before it acquires Arch. To complete the acquisition of
Arch, Foccini has also agreed to raise $5Million by way of a private placement.
The proceeds will be used for funding drug development conducted by Arch and
general and administrative expenses.


If the option is exercised, Foccini will issue a total of 14,200,000 common
shares to the owners of Arch to complete the transaction. There will be no other
consideration paid for the purchase of Arch Biotech Inc. These shares will be
issued at a deemed price of $0.05 per share for a total value of $710,000.


About Foccini's current Merchandising Business

Foccini Trade GmbH ("FT"), based in Austria, is a merchandising, design and
advertising company 100% owned by Foccini. FT focuses on strengthening the
brands of corporate clients.


Foccini will be required to sell its entire stake in FT in the event it
exercises the option to acquire Arch. Terms of the sale of Foccini Trade will be
disclosed once the sale is negotiated and completed.


For more information on FT's business operations, please refer to Foccini's most
recent Management Discussion and Analysis which was filed on April 30, 2009 at
www.SEDAR.com.


Non Arm's Length Parties

Richard Muruve is both a director of Foccini International and a director of
Arch Biotech Inc. He owns over 10% of Foccini's common shares outstanding. He is
a minor shareholder of Arch Biotech and brother of Dr. Daniel Muruve, one of the
owners of Arch. Subject to securities regulations, Mr. Richard Muruve will be
abstaining from the possible shareholder vote regarding the approval of
Foccini's acquisition of Arch.


Foccini currently has 27,321,179 common shares issued and outstanding.

There can be no assurance Foccini will exercise the option to acquire Arch. If
the option is exercised, completion of the Transaction is subject to a number of
conditions, including Exchange acceptance and disinterested Shareholder
approval. The Transaction cannot close until the required Shareholder approval
is obtained. There can be no assurance that the Transaction will be completed as
proposed or at all.


Investors are cautioned that, except as disclosed in a Management Information
Circular to be prepared in connection with the potential Transaction, any
information released or received with respect to the Change of Business may not
be accurate or complete and should not be relied upon. Trading in the securities
of Foccini International Inc should be considered highly speculative.


The TSX Venture Exchange has in no way passed upon the merits of the proposed
transaction and has neither approved nor disapproved the contents of this press
release.


For more information on Foccini, please consult the other public documents filed
on SEDAR at www.sedar.com.


Forward-Looking Statements

All statements, other than statements of historical fact, in this news release
are forward looking statements that involve various risks and uncertainties,
including, without limitation, statements regarding the future plans and
objectives of the Company. There can be no assurance that such statements will
prove to be accurate. Actual results and future events could differ materially
from those anticipated in such statements. These and all subsequent written and
oral forward-looking statements are based on the estimates and opinions of
management on the dates they are made and are expressly qualified in their
entirety by this notice. The Company assumes no obligation to update
forward-looking statements should circumstances or management's estimates or
opinions change.

Foccini International (TSXV:FOI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

Foccini International (TSXV:FOI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024